Status:

COMPLETED

Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure

Lead Sponsor:

King's College London

Collaborating Sponsors:

National Institute for Health Research, United Kingdom

London School of Hygiene and Tropical Medicine

Conditions:

Ischemic Cardiomyopathy

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will assess whether percutaneous coronary intervention (angioplasty of the heart arteries) can improve survival and reduce hospitalization in patients with heart failure due to coronary dis...

Eligibility Criteria

Inclusion

  • ALL of the following:
  • Poor left ventricular function (EF≤35%)
  • Extensive coronary disease
  • Viability in at least 4 dysfunctional segments that can be revascularised by PCI

Exclusion

  • Myocardial infarction \< 4 weeks prior to randomisation (clinical definition)
  • Decompensated heart failure requiring inotropic support, invasive or non-invasive ventilation or Intra-aortic Balloon Pump/left ventricular assist device therapy \<72 hours prior to randomization
  • Sustained Ventricular Tachycardia/Ventricular Fibrillation or appropriate Implantable Cardioverter Defibrillator discharges \<72 hours prior to randomization
  • Valve disease requiring intervention
  • Contraindications to percutaneous coronary intervention
  • Age \<18 yrs
  • Estimated Glomerular Filtration Rate \< 25 ml/min, unless established on dialysis
  • Women who are pregnant
  • Previously enrolled in REVIVED-BCIS2 or current enrollment in other study that may affect REVIVED-BCIS2 outcome data
  • Life expectancy \< 1 yr due to non-cardiac pathology

Key Trial Info

Start Date :

August 28 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 31 2022

Estimated Enrollment :

700 Patients enrolled

Trial Details

Trial ID

NCT01920048

Start Date

August 28 2013

End Date

March 31 2022

Last Update

May 31 2022

Active Locations (40)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 10 (40 locations)

1

Basingstoke and North Hampshire Hospital

Basingstoke, United Kingdom, RG24 9NA

2

Royal Victoria Hospital

Belfast, United Kingdom, BT12 6BA

3

Birmingham Heartlands Hospital

Birmingham, United Kingdom, B9 5SS

4

Blackpool Victoria Hospital

Blackpool, United Kingdom, FY3 8NR